Cardiovascular complications are responsible not only for the high mortality, but also the morbidity of end-stage renal disease patients. Cyclic changes of fluid load, together with the altered metabolism, are responsible and are mirrored in many particular parts of the heart. A review of the mechanisms involved is presented and the role of dialysis access is highlighted.
MalikJKudlickaJLachmanovaJet al. Tissue ischemia worsens during hemodialysis in end-stage renal disease patients. J Vasc Access. 2017;18(1):47–51.
2.
RoncoCHaapioMHouseAAAnavekarNBellomoR. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527–1539.
3.
ChawlaLSHerzogCACostanzoMRet al. ADQI XI Workgroup. Proposal for a functional classification system of heart failure in patients with end-stage renal disease: proceedings of the acute dialysis quality initiative (ADQI) XI workgroup. J Am Coll Cardiol. 2014;63(13):1246–1252.
4.
HicksonLJNegrottoSMOnuigboMet al. Echocardiography Criteria for Structural Heart Disease in Patients With End-Stage Renal Disease Initiating Hemodialysis. J Am Coll Cardiol. 2016;67(10):1173–1182.
5.
SavageMTFerroCJSassanoATomsonCR. The impact of arteriovenous fistula formation on central hemodynamic pressures in chronic renal failure patients: a prospective study. Am J Kidney Dis. 2002;40(4):753–759.
6.
RagostaMSamadyHIsaacsRBGimpleLWSarembockIJPowersER. Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries. Am Heart J. 2004;147(6):1017–1023.
7.
McIntyreCW. Effects of hemodialysis on cardiac function. Kidney Int. 2009;76(4):371–375.
8.
DavidsonIBeathardGGallieniMRossJ. The DRIL procedure for arteriovenous access ischemic steal: a controversial approach. J Vasc Access. 2017;18(1):1–2.
9.
KorsheedSEldehniMTJohnSGFluckRJMcIntyreCW. Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function. Nephrol Dial Transplant. 2011;26(10):3296–3302.
10.
AhnSHanAKimSYet al. The incidence and risk factors of coronary steal after ipsilateral AVF in patients with a coronary artery bypass graft. J Vasc Access. 2017;18(4):290–294.
PlutaAStróżeckiPKrintusMOdrowąż-SypniewskaGManitiusJ. Left ventricular remodeling and arterial remodeling in patients with chronic kidney disease stage 13. Ren Fail. 2015;37(7):1105–1110.
13.
ParkMHsuCYLiYet al. Chronic Renal Insufficiency Cohort (CRIC) Study Group. Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol. 2012;23(10):1725–1734.
14.
HewingBDehnAMStaeckOet al. Improved Left Ventricular Structure and Function After Successful Kidney Transplantation. Kidney Blood Press Res. 2016;41(5):701–709.
15.
Leifheit-NestlerMGroße SiemerRFlasbartKet al. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease. Nephrol Dial Transplant. 2016;31(7):1088–1099.
16.
KennedyDJMalhotraDShapiroJI. Molecular insights into uremic cardiomyopathy: cardiotonic steroids and Na/K ATPase signaling. Cell Mol Biol (Noisy-le-grand). 2006;52(8):3–14.
17.
FoleyRNParfreyPSHarnettJDKentGMMurrayDCBarréPE. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol. 1995;5(12):2024–2031.
18.
MostovayaIMBotsMLvan den DorpelMAet al. Left ventricular mass in dialysis patients, determinants and relation with outcome. Results from the COnvective TRansport STudy (CONTRAST). PLoS ONE. 2014;9(2):e84587.
19.
de Roij van ZuijdewijnCLHansildaarRBotsMLet al. Eccentric Left Ventricular Hypertrophy and Sudden Death in Patients with End-Stage Kidney Disease. Am J Nephrol. 2015;42(2):126–133.
20.
MovilliEViolaBFBrunoriGet al. Long-term effects of arteriovenous fistula closure on echocardiographic functional and structural findings in hemodialysis patients: a prospective study. Am J Kidney Dis. 2010;55(4):682–689.
21.
IoHAizawaMFunabikiKHorikoshiSTominoY. Impact of anaemia treatment for left ventricular remodelling prior to initiation of dialysis in chronic kidney disease patients: Efficacy and stability of long acting erythropoietin stimulating agents. Nephrology (Carlton). 2015;20(Suppl 4):7–13.
22.
MalikJLachmanovaJKudlickaJet al. Left Atrial Dysfunction in End-Stage Renal Disease Patients Treated by Hemodialysis. Nephron. 2016;133(3):169–174.
23.
IwashimaYHorioTTakamiYet al. Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. Am J Kidney Dis. 2002;40(5):974–982.
24.
JefferiesHJBurtonJOMcIntyreCW. Individualised dialysate temperature improves intradialytic haemodynamics and abrogates haemodialysis-induced myocardial stunning, without compromising tolerability. Blood Purif. 2011;32(1):63–68.
25.
BurtonJOJefferiesHJSelbyNMMcIntyreCW. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol. 2009;4(12):1925–1931.
26.
KorsheedSBurtonJOMcIntyreCW. Higher arteriovenous fistulae blood flows are associated with a lower level of dialysis-induced cardiac injury. Hemodial Int. 2009;13(4):505–511.
27.
LekawanvijitSKompaARManabeMet al. Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate. PLoS ONE. 2012;7(7):e41281.
28.
Roca-TeyR. Permanent arteriovenous fistula or catheter dialysis for heart failure patients. J Vasc Access. 2016;17(Suppl 1):S23–S29.
29.
JeongJHWuPTKistlerBMet al. The presence and impact of diastolic dysfunction on physical function and body composition in hemodialysis patients. J Nephrol. 2015;28(6):739–747.
30.
HungKCLeeCHChenCCet al. Advanced left ventricular diastolic dysfunction in uremic patients with type 2 diabetes on maintenance hemodialysis. Circ J. 2012;76(10):2380–2385.
31.
HeeLNguyenTWhatmoughMet al. Left atrial volume and adverse cardiovascular outcomes in unselected patients with and without CKD. Clin J Am Soc Nephrol. 2014;9(8):1369–1376.
32.
van de VeerdonkMCBogaardHJVoelkelNF. The right ventricle and pulmonary hypertension. Heart Fail Rev. 2016;21(3):259–271.
33.
KuoFYHuangWCChiouKRet al. Myocardial Tissue Doppler Imaging Detects Right Ventricular Dysfunction after Percutaneous Angioplasty of Dysfunctional Hemodialysis Access in Uremic Patients. Acta Cardiol Sin. 2014;30(2):136–143.
34.
HavlucuYKursatSEkmekciCet al. Pulmonary hypertension in patients with chronic renal failure. Respiration. 2007;74(5):503–510.
35.
BolignanoDRastelliSAgarwalRet al. Pulmonary hypertension in CKD. Am J Kidney Dis. 2013;61(4):612–622.
36.
AgarwalR. Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients. Nephrol Dial Transplant. 2012;27(10):3908–3914.
37.
BeigiAASadeghiAMKhosraviARKaramiMMasoudpourH. Effects of the arteriovenous fistula on pulmonary artery pressure and cardiac output in patients with chronic renal failure. J Vasc Access. 2009;10(3):160–166.
BaktirogluSYanarFOzataIHOnerGErcanD. Arterial disease and vascular access in diabetic patients. J Vasc Access. 2016;17(Suppl 1):S69–S71.
40.
RosenbergJEAstorBCDelucaHFYevzlinAS. The association of mineral metabolism with vascular access patency. J Vasc Access. 2016;17(5):392–396.
41.
DadTSarnakMJ. Pericarditis and Pericardial Effusions in End-Stage Renal Disease. Semin Dial. 2016;29(5):366–373.
42.
CordeiroACAmparoFCOliveiraMAet al. Epicardial fat accumulation, cardiometabolic profile and cardiovascular events in patients with stages 35 chronic kidney disease. J Intern Med. 2015;278(1):77–87.
43.
WolfPWinhoferYSmajisSet al. Pericardial- Rather than Intramyocardial Fat Is Independently Associated with Left Ventricular Systolic Heart Function in Metabolically Healthy Humans. PLoS ONE. 2016;11(3):e0151301.
44.
NickelPGülSPuhlGPoellingerASchindlerR. Acute cardiorenal syndrome by high flow arteriovenous fistula after kidney transplantation. J Vasc Access. 2013;14(4):394–396.
45.
RoncoFMazzonePHosseinianLGenovesiS. Recent Advances in Stroke Prevention in Patients with Atrial Fibrillation and End-Stage Renal Disease. Cardiorenal Med. 2017;7(3):207–217.
46.
ReddyYNMelenovskyVRedfieldMMNishimuraRABorlaugBA. High-Output Heart Failure: A 15-Year Experience. J Am Coll Cardiol. 2016;68(5):473–482.
47.
WohlfahrtPRokosnySMelenovskyVBorlaugBAPecenkovaVBalazP. Cardiac remodeling after reduction of high-flow arteriovenous fistulas in end-stage renal disease. Hypertens Res. 2016;39(9):654–659.
48.
Al-GhonaimMMannsBJHirschDJGaoZTonelliM. Network AKD; Alberta Kidney Disease Network. Relation between access blood flow and mortality in chronic hemodialysis patients. Clin J Am Soc Nephrol. 2008;3(2):387–391.
49.
ChemlaESMorsyMAndersonLWhitemoreA. Inflow reduction by distalization of anastomosis treats efficiently high-inflow high-cardiac output vascular access for hemodialysis. Semin Dial. 2007;20(1):68–72.
50.
SoleymanianTSheikhVTarehFArganiHOssarehS. Hemodialysis vascular access and clinical outcomes: an observational multicenter study. J Vasc Access. 2017;18(1):35–42.
51.
OttCLoboMDSobotkaPAet al. Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension. J Am Heart Assoc. 2016;5(12):e004234.
KorsheedSEldehniMTJohnSGFluckRJMcIntyreCW. Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function. Nephrol Dial Transplant. 2011;26(10):3296–3302.
